Translational Development Acquisition TDAC
NASDAQ TDAC
$10.84 -0.01 (-0.09%)
At close: Aug 20, 2026 · 4:00 PM EDT

Translational Development Acquisition (TDAC) Return on Assets (2025 - 2026)

Translational Development Acquisition's (TDAC) quarterly Return on Assets came in at 0.0% in Q1 2026, little changed YoY from 0.0% in Q1 2025, and up 7.87% on a QoQ basis from 0.0% in Q4 2025.

Translational Development Acquisition (TDAC) Return on Assets (2025 - 2026) Analysis & Trends

Translational Development Acquisition (TDAC) has 2 years of Return on Assets data on file, last reported at 0.0% in Q1 2026.

  • Quarterly Return on Assets changed 0.0% year-over-year to 0.0% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.0% (changed 0.0% YoY) and the FY2025 annual result came in at 0.0%, changed 0.0% from the prior year.
  • Return on Assets grew to 0.0% in Q1 2026, from 0.0% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.0% in Q1 2025 to a low of 0.0% in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Launch Two Acquisition 557.86 Mn 557.86 Mn - 0.00%
2 Drugs Made In America Acquisition 507.00 Mn 507.00 Mn - 0.00%
3 Cantor Equity Partners IV 467.55 Mn 467.55 Mn - 0.00%
4 GP-Act III Acquisition 401.06 Mn 401.06 Mn - 0.00%
5 Aldel Financial 397.49 Mn 397.49 Mn - 0.00%
6 Gores Holdings X 381.05 Mn 380.85 Mn - 0.00%
7 Agriculture & Natural Solutions Acquisition 377.29 Mn 377.04 Mn - 0.00%
8 Blue Water Acquisition Corp. III 342.12 Mn 342.08 Mn - 0.00%
9 Berto Acquisition 313.96 Mn 313.81 Mn - 0.00%
10 Translational Development Acquisition 182.66 Mn 182.57 Mn - 0.00%

Historic Data

Download Data
DateValue
Mar 31, 2026 0.00%
Dec 31, 2025 0.00%
Sep 30, 2025 0.00%
Jun 30, 2025 0.00%
Mar 31, 2025 0.00%